Biomed Industries to Advance NA-931 Into Two Global Phase 3 Trials as Monotherapy and in Combination With Semaglutide and Tirzepatide for Obesity Advancing NA-931 into two Phase 3 programs as ...

Atsena Therapeutics, a clinical-stage gene therapy company focused on using the life-changing power of genetic medicine to reverse or prevent blindness, today announced that dosing is complete in ...

Company on track to report ELEVATE-44-201 data from the first cohort in Q2 2026 and ELEVATE-45-201 data from the first cohort in mid-2026 - ...

Company also announces renaming of Toliara Project to Vara Mada to better reflect the project's positive benefits to Madagascar and its global ...

Acousia Therapeutics GmbH, a clinical-stage biotechnology company developing treatments for acute and chronic inner ear hearing loss, announced ...

The Sycamore Youth Center has announced registration is open for after-school classes for the winter and spring semester. Classes run from Jan. 26 through May 1, with courses offered to students in ...

The Montgomery Township Board of Supervisors voted 3-2 Monday night to reopen the township’s adopted 2026 budget, setting the ...

Solar physicists say they have found a key source of intense gamma rays unleashed when Earth’s nearest star produces its most ...

Introduction After the WHO prequalified the first vaccine against mpox, we aimed to identify the influence of vaccine ...

The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...

Meanwhile, in attempts to address long-standing thyroid cancer concerns, a research team conducted a 350,000-person analysis ...

UCSD and the Department of Veterans Affairs Collaboration CARLSBAD, CA, UNITED STATES, December 31, 2025 /EINPresswire.com/ — AVACEN Medical announced today that Dr. Francisco Cidral, ND, PhD’s ...